Laboratory of Pathology, Department of Pathology, State Key Laboratoty of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China.
World J Gastroenterol. 2012 Nov 28;18(44):6501-3. doi: 10.3748/wjg.v18.i44.6501.
An extrahepatic arterioportal fistula (APF) involving the gastroduodenal artery and superior mesenteric vein is rare and mostly results from iatrogenic injuries. The clinical symptoms associated with APFs may include abdominal pain, gastrointestinal bleeding, ascites, nausea, vomiting, diarrhea, or even congestive heart failure. We present the case of a 70-year-old man who presented with chronic abdominal pain and gastrointestinal bleeding secondary to APF and portal vein thrombosis. The endovascular embolization of APF was accomplished successfully, and symptoms of portal hypertension resolved immediately after intervention. Unfortunately, the patient did not respond well to anticoagulation therapy with warfarin. Therefore, the patient underwent implantation of a transjugular intrahepatic portosystemic shunt, and the complications of portal hypertension resolved. In conclusion, the embolization of APF is technically feasible and effective and can be considered the first-choice therapy in selected patients.
肝外性动静脉瘘(APF)累及胃十二指肠动脉和肠系膜上静脉较为罕见,主要由医源性损伤所致。APF 相关的临床症状可能包括腹痛、胃肠道出血、腹水、恶心、呕吐、腹泻,甚至充血性心力衰竭。我们报告了一例 70 岁男性患者,因 APF 和门静脉血栓形成导致慢性腹痛和胃肠道出血。成功进行了 APF 的血管内栓塞,介入治疗后门静脉高压的症状立即得到缓解。不幸的是,患者对华法林抗凝治疗反应不佳。因此,患者接受了经颈静脉肝内门体分流术(TIPS)植入术,门静脉高压的并发症得到解决。总之,APF 的栓塞在技术上是可行和有效的,并且可以在选择的患者中作为首选治疗方法。